Key statistics
On Friday, Dr Reddy's Laboratories Ltd (RDY:NYQ) closed at 13.99, 8.45% above its 52-week low of 12.90, set on Dec 11, 2023.
52-week range
Open | 14.05 |
---|---|
High | 14.25 |
Low | 13.93 |
Bid | 13.71 |
Offer | 14.19 |
Previous close | 14.30 |
Average volume | 993.96k |
---|---|
Shares outstanding | 833.05m |
Free float | -- |
P/E (TTM) | 18.48 |
Market cap | 11.80bn USD |
EPS (TTM) | 0.757 USD |
Annual div (ADY) | 0.0952 USD |
---|---|
Annual div yield (ADY) | 0.68% |
Div ex-date | Jul 30 2024 |
Div pay-date | Aug 12 2024 |
Data delayed at least 15 minutes, as of Nov 22 2024.
More ▼
- Dr. Reddy’s Q2 & H1FY25 Financial Results
- Dr. Reddy's Named by Science Magazine in Top 20 Global Pharma Employers List for Third Consecutive Year
- Dr. Reddy’s Launches Comprehensive Menopause Support Program and Training for Employees During Menopause Awareness Month
- Aurigene Oncology Limited Announces Promising Results of Phase 1 Study for India’s First Trial for Novel Autologous CAR-T Cell Therapy for Multiple Myeloma
- Dr. Reddy’s signs voluntary licensing agreement with Gilead Sciences to manufacture and commercialise Lenacapavir in India and other countries
More ▼